Demonstrates liver function improvement in acute liver injury using vesicle gene therapy, indicating therapeutic potential.
significantly suppressed HSCs activation, reduced inflammation and hepatocyte apoptosis, improved liver function, and alleviated liver fibrosis in experimental models. This work highlights a promising strategy that combines targeted vesicle delivery with gene therapy, offering a potential avenue for improving the precision and efficacy of treatments for liver injury and fibrosis.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Nanobiotechnology